Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

A kind of valacyclovir hydrochloride liposome tablet and preparation method thereof

A technology of valacyclovir hydrochloride and valacyclovir lipid, which is applied in the field of preparation of valacyclovir hydrochloride liposome tablets, can solve problems such as unfavorable stability of valacyclovir hydrochloride, and achieve good tabletability and stability The effect of good resistance and good disintegration performance

Active Publication Date: 2022-04-22
药大制药有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But adding alkaline substances is more unfavorable for the stability of acidic valacyclovir hydrochloride

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] A preparation method of valacyclovir hydrochloride liposome tablet, comprising the following steps:

[0024] (1) Preparation of valacyclovir hydrochloride liposomes: Weigh 1 g of valacyclovir hydrochloride, 1 g of cholesterol and 8 g of soybean lecithin and dissolve them in a mixed solution of dichloromethane and methanol with a volume ratio of 3:1 , and then remove the solvent under vacuum at 60 °C on a rotary evaporator to obtain a thin film, and continue to evaporate for 2 hours to completely remove all traces of solvent and obtain a dry film; the dry film is added at 45 °C with an appropriate amount of 6g polyethylene. Pyrrolidone-K30 was hydrated in 20 mL of phosphate buffer for 15 minutes to obtain a liposome solution; the obtained liposomes were sonicated for 5 minutes to obtain small and uniform vesicles, and the obtained dried lipids were lyophilized The body powder was sieved through an 80-mesh sieve and stored at 4°C until use;

[0025] (2) Mixing: 1 g of li...

Embodiment 2

[0028] A preparation method of valacyclovir hydrochloride liposome tablet, comprising the following steps:

[0029] (1) Preparation of valacyclovir hydrochloride liposomes: Weigh 1 g of valacyclovir hydrochloride, 1 g of cholesterol and 8 g of soybean lecithin and dissolve them in a mixed solution of dichloromethane and methanol with a volume ratio of 3:1 , and then remove the solvent under vacuum at 60 °C on a rotary evaporator to obtain a thin film, and continue to evaporate for 2 hours to completely remove all traces of solvent and obtain a dry film; the dry film is added at 45 °C with an appropriate amount of 6g polyethylene. Pyrrolidone-K30 was hydrated in 20 mL of phosphate buffer for 15 minutes to obtain a liposome solution; the obtained liposomes were sonicated for 5 minutes to obtain small and uniform vesicles, and the obtained dried lipids were lyophilized The body powder was sieved through an 80-mesh sieve and stored at 4°C until use;

[0030] (2) Mixing: 1 g of li...

Embodiment 3

[0033] A preparation method of valacyclovir hydrochloride liposome tablet, comprising the following steps:

[0034] (1) Preparation of valacyclovir hydrochloride liposomes: Weigh 1 g of valacyclovir hydrochloride, 1 g of cholesterol and 8 g of soybean lecithin and dissolve them in a mixed solution of dichloromethane and methanol with a volume ratio of 3:1 , and then remove the solvent under vacuum at 60 °C on a rotary evaporator to obtain a thin film, and continue to evaporate for 2 hours to completely remove all traces of solvent and obtain a dry film; the dry film is added at 45 °C with an appropriate amount of 6g polyethylene. Pyrrolidone-K30 was hydrated in 20 mL of phosphate buffer for 15 minutes to obtain a liposome solution; the obtained liposomes were sonicated for 5 minutes to obtain small and uniform vesicles, and the obtained dried lipids were lyophilized The body powder was sieved through an 80-mesh sieve and stored at 4°C until use;

[0035](2) Mixing: 1 g of lip...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a valacyclovir hydrochloride liposome tablet, comprising valacyclovir hydrochloride liposome, filler, excipient, disintegrating agent, binder and lubricant, valacyclovir hydrochloride Liposome is made up of valacyclovir hydrochloride, cholesterol, soybean lecithin and polyvinylpyrrolidone-K30; The preparation method of valacyclovir hydrochloride liposome tablet comprises the steps: (1) valacyclovir hydrochloride fat Preparation of plastids, (2) mixing, (3) tableting. The present invention adopts specific auxiliary material and selects suitable proportioning, obtains a kind of valacyclovir hydrochloride liposome tablet with good stability, excellent disintegration performance, high bioavailability; Valacyclovir hydrochloride liposome tablet of the present invention The plastid tablet not only has stability and bioavailability much higher than that of prior art products, but also brings great convenience to clinical medication.

Description

technical field [0001] The invention relates to the technical field of medical science and technology, in particular to the preparation and application of a valacyclovir hydrochloride liposome tablet. Background technique [0002] Valacyclovir hydrochloride is L-valine-2-[(6-oxo-2-amino-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl ester hydrochloride , the English name is Valaciclovir Hydrochloride. [0003] Valacyclovir hydrochloride is a prodrug of acyclovir (ACV), which is rapidly absorbed after oral administration and rapidly converted into acyclovir in the body. Its antiviral effect is caused by the action of the parent acyclovir. Ciclovir is an open-chain purine nucleoside that inhibits viral DNA synthesis and has less effect on host cell DNA synthesis. After acyclovir enters into herpes-infected cells, it competes with deoxynucleosides for viral thymidine kinase or cellular kinase, and the drug is phosphorylated into activated acyclovir triphosphate, which acts as a subs...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/20A61K47/36A61K47/32A61K9/127A61K31/522A61P31/22
CPCA61K9/205A61K9/2027A61K9/127A61K31/522A61P31/22
Inventor 郝静梅
Owner 药大制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com